ID   ACM3_RAT                Reviewed;         589 AA.
AC   P08483; Q9QWK9;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1988, sequence version 1.
DT   02-OCT-2024, entry version 197.
DE   RecName: Full=Muscarinic acetylcholine receptor M3;
GN   Name=Chrm3; Synonyms=Chrm-3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=3037705; DOI=10.1126/science.3037705;
RA   Bonner T.I., Buckley N.J., Young A.C., Brann M.R.;
RT   "Identification of a family of muscarinic acetylcholine receptor genes.";
RL   Science 237:527-532(1987).
RN   [2]
RP   SEQUENCE REVISION TO 184.
RX   PubMed=3272174; DOI=10.1016/0896-6273(88)90190-0;
RA   Bonner T.I., Young A.C., Brann M.R., Buckley N.J.;
RT   "Cloning and expression of the human and rat m5 muscarinic acetylcholine
RT   receptor genes.";
RL   Neuron 1:403-410(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=3120722; DOI=10.1016/0006-291x(87)91613-5;
RA   Braun T., Schofield P.R., Shivers B.D., Pritchett D.B., Seeburg P.H.;
RT   "A novel subtype of muscarinic receptor identified by homology screening.";
RL   Biochem. Biophys. Res. Commun. 149:125-132(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Iris;
RX   PubMed=9972520; DOI=10.1540/jsmr.34.111;
RA   Furuta M., Ohya S., Imaizumi Y., Watanabe M.;
RT   "Molecular cloning of m3 muscarinic acetylcholine receptor in rat iris.";
RL   J. Smooth Muscle Res. 34:111-122(1998).
RN   [5]
RP   PROTEIN SEQUENCE OF 104-166.
RX   PubMed=2380182; DOI=10.1016/s0021-9258(18)77406-1;
RA   Kurtenbach E., Curtis C.A.M., Pedder E.K., Aitken A., Harris A.C.M.,
RA   Hulme E.C.;
RT   "Muscarinic acetylcholine receptors. Peptide sequencing identifies residues
RT   involved in antagonist binding and disulfide bond formation.";
RL   J. Biol. Chem. 265:13702-13708(1990).
RN   [6]
RP   MUTAGENESIS OF TYR-148; THR-231; THR-234; TYR-506; TYR-529 AND TYR-533,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=1657592; DOI=10.1002/j.1460-2075.1991.tb04941.x;
RA   Wess J., Gdula D., Brann M.R.;
RT   "Site-directed mutagenesis of the m3 muscarinic receptor: identification of
RT   a series of threonine and tyrosine residues involved in agonist but not
RT   antagonist binding.";
RL   EMBO J. 10:3729-3734(1991).
RN   [7]
RP   MUTAGENESIS OF THR-234 AND TYR-506, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=1527051; DOI=10.1016/s0021-9258(18)41776-0;
RA   Wess J., Maggio R., Palmer J.R., Vogel Z.;
RT   "Role of conserved threonine and tyrosine residues in acetylcholine binding
RT   and muscarinic receptor activation. A study with m3 muscarinic receptor
RT   point mutants.";
RL   J. Biol. Chem. 267:19313-19319(1992).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (3.40 ANGSTROMS) OF 57-589 IN COMPLEX WITH THE
RP   INVERSE AGONIST TIOTROPIUM, FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, AND
RP   DISULFIDE BOND.
RX   PubMed=22358844; DOI=10.1038/nature10867;
RA   Kruse A.C., Hu J., Pan A.C., Arlow D.H., Rosenbaum D.M., Rosemond E.,
RA   Green H.F., Liu T., Chae P.S., Dror R.O., Shaw D.E., Weis W.I., Wess J.,
RA   Kobilka B.K.;
RT   "Structure and dynamics of the M3 muscarinic acetylcholine receptor.";
RL   Nature 482:552-556(2012).
CC   -!- FUNCTION: The muscarinic acetylcholine receptor mediates various
CC       cellular responses, including inhibition of adenylate cyclase,
CC       breakdown of phosphoinositides and modulation of potassium channels
CC       through the action of G proteins. Primary transducing effect is Pi
CC       turnover. {ECO:0000269|PubMed:1527051, ECO:0000269|PubMed:1657592,
CC       ECO:0000269|PubMed:22358844}.
CC   -!- SUBUNIT: Homodimer; the dimers can form tetramers (By similarity).
CC       Interacts with NALCN (By similarity). Interacts with TMEM147 (By
CC       similarity). {ECO:0000250|UniProtKB:P20309,
CC       ECO:0000250|UniProtKB:Q9ERZ3}.
CC   -!- INTERACTION:
CC       P08483; P11275: Camk2a; NbExp=2; IntAct=EBI-7946407, EBI-2640645;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1527051};
CC       Multi-pass membrane protein {ECO:0000255}. Postsynaptic cell membrane;
CC       Multi-pass membrane protein {ECO:0000255}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:P20309}; Multi-pass membrane protein
CC       {ECO:0000255}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P20309}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Colocalizes with TMEM147 in the endoplasmic
CC       reticulum (ER) membrane. TMEM147 impairs its trafficking to the cell
CC       membrane leading to its retention in the ER membrane.
CC       {ECO:0000250|UniProtKB:P20309}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Muscarinic acetylcholine receptor subfamily. CHRM3 sub-subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M16407; AAA40661.1; -; mRNA.
DR   EMBL; M16408; AAA40662.1; -; Genomic_DNA.
DR   EMBL; M18088; AAA40659.1; -; mRNA.
DR   EMBL; M62826; AAA41553.1; -; Genomic_DNA.
DR   EMBL; AB017656; BAA36839.1; -; mRNA.
DR   PIR; A29476; A29476.
DR   PIR; B94518; B29514.
DR   RefSeq; NP_036659.2; NM_012527.2.
DR   RefSeq; XP_017455938.1; XM_017600449.1.
DR   RefSeq; XP_017455939.1; XM_017600450.1.
DR   RefSeq; XP_017455940.1; XM_017600451.1.
DR   RefSeq; XP_017455941.1; XM_017600452.1.
DR   PDB; 4DAJ; X-ray; 3.40 A; A/B/C/D=57-259, A/B/C/D=482-589.
DR   PDB; 4U14; X-ray; 3.57 A; A=57-259, A=482-563.
DR   PDB; 4U15; X-ray; 2.80 A; A/B=57-259, A/B=482-563.
DR   PDB; 4U16; X-ray; 3.70 A; A/B=57-259, A/B=482-563.
DR   PDB; 5ZHP; X-ray; 3.10 A; A/B=57-308, A/B=482-569.
DR   PDBsum; 4DAJ; -.
DR   PDBsum; 4U14; -.
DR   PDBsum; 4U15; -.
DR   PDBsum; 4U16; -.
DR   PDBsum; 5ZHP; -.
DR   AlphaFoldDB; P08483; -.
DR   SMR; P08483; -.
DR   IntAct; P08483; 1.
DR   MINT; P08483; -.
DR   STRING; 10116.ENSRNOP00000067435; -.
DR   BindingDB; P08483; -.
DR   ChEMBL; CHEMBL320; -.
DR   DrugCentral; P08483; -.
DR   GuidetoPHARMACOLOGY; 15; -.
DR   GlyCosmos; P08483; 5 sites, No reported glycans.
DR   GlyGen; P08483; 5 sites.
DR   iPTMnet; P08483; -.
DR   PhosphoSitePlus; P08483; -.
DR   PaxDb; 10116-ENSRNOP00000067435; -.
DR   Ensembl; ENSRNOT00000075651.3; ENSRNOP00000067435.1; ENSRNOG00000049410.3.
DR   Ensembl; ENSRNOT00000102670.1; ENSRNOP00000090085.1; ENSRNOG00000049410.3.
DR   Ensembl; ENSRNOT00000103154.1; ENSRNOP00000090433.1; ENSRNOG00000049410.3.
DR   Ensembl; ENSRNOT00000107962.1; ENSRNOP00000086603.1; ENSRNOG00000049410.3.
DR   Ensembl; ENSRNOT00000113544.1; ENSRNOP00000087869.1; ENSRNOG00000049410.3.
DR   Ensembl; ENSRNOT00000118676.1; ENSRNOP00000080306.1; ENSRNOG00000049410.3.
DR   Ensembl; ENSRNOT00055010622; ENSRNOP00055008232; ENSRNOG00055006531.
DR   Ensembl; ENSRNOT00055010623; ENSRNOP00055008233; ENSRNOG00055006531.
DR   Ensembl; ENSRNOT00055010624; ENSRNOP00055008234; ENSRNOG00055006531.
DR   Ensembl; ENSRNOT00055010625; ENSRNOP00055008235; ENSRNOG00055006531.
DR   Ensembl; ENSRNOT00055010626; ENSRNOP00055008236; ENSRNOG00055006531.
DR   Ensembl; ENSRNOT00055010627; ENSRNOP00055008237; ENSRNOG00055006531.
DR   Ensembl; ENSRNOT00060027067; ENSRNOP00060021705; ENSRNOG00060015814.
DR   Ensembl; ENSRNOT00060027072; ENSRNOP00060021708; ENSRNOG00060015814.
DR   Ensembl; ENSRNOT00060027081; ENSRNOP00060021713; ENSRNOG00060015814.
DR   Ensembl; ENSRNOT00060027087; ENSRNOP00060021718; ENSRNOG00060015814.
DR   Ensembl; ENSRNOT00060027093; ENSRNOP00060021723; ENSRNOG00060015814.
DR   Ensembl; ENSRNOT00060027096; ENSRNOP00060021726; ENSRNOG00060015814.
DR   Ensembl; ENSRNOT00065035392; ENSRNOP00065028502; ENSRNOG00065020850.
DR   Ensembl; ENSRNOT00065035397; ENSRNOP00065028505; ENSRNOG00065020850.
DR   Ensembl; ENSRNOT00065035402; ENSRNOP00065028510; ENSRNOG00065020850.
DR   Ensembl; ENSRNOT00065035405; ENSRNOP00065028513; ENSRNOG00065020850.
DR   Ensembl; ENSRNOT00065035411; ENSRNOP00065028519; ENSRNOG00065020850.
DR   GeneID; 24260; -.
DR   KEGG; rno:24260; -.
DR   UCSC; RGD:2343; rat.
DR   AGR; RGD:2343; -.
DR   CTD; 1131; -.
DR   RGD; 2343; Chrm3.
DR   eggNOG; KOG4220; Eukaryota.
DR   GeneTree; ENSGT00940000160084; -.
DR   HOGENOM; CLU_009579_11_2_1; -.
DR   InParanoid; P08483; -.
DR   OMA; CGGREMI; -.
DR   OrthoDB; 4136179at2759; -.
DR   PhylomeDB; P08483; -.
DR   TreeFam; TF320495; -.
DR   Reactome; R-RNO-390648; Muscarinic acetylcholine receptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   EvolutionaryTrace; P08483; -.
DR   PRO; PR:P08483; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   Bgee; ENSRNOG00000049410; Expressed in frontal cortex and 12 other cell types or tissues.
DR   GO; GO:0032279; C:asymmetric synapse; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0042166; F:acetylcholine binding; IDA:UniProtKB.
DR   GO; GO:0016907; F:G protein-coupled acetylcholine receptor activity; IDA:UniProtKB.
DR   GO; GO:0031789; F:G protein-coupled acetylcholine receptor binding; IDA:RGD.
DR   GO; GO:0004993; F:G protein-coupled serotonin receptor activity; IBA:GO_Central.
DR   GO; GO:0050997; F:quaternary ammonium group binding; IDA:RGD.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007197; P:adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0007213; P:G protein-coupled acetylcholine receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IBA:GO_Central.
DR   GO; GO:0099105; P:ion channel modulating, G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:1990806; P:ligand-gated ion channel signaling pathway; ISO:RGD.
DR   GO; GO:0003063; P:negative regulation of heart rate by acetylcholine; IMP:RGD.
DR   GO; GO:0007207; P:phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway; ISO:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0045987; P:positive regulation of smooth muscle contraction; ISO:RGD.
DR   GO; GO:1904695; P:positive regulation of vascular associated smooth muscle contraction; IMP:RGD.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IMP:RGD.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; IBA:GO_Central.
DR   GO; GO:1905144; P:response to acetylcholine; IMP:RGD.
DR   GO; GO:0046541; P:saliva secretion; ISO:RGD.
DR   GO; GO:0006939; P:smooth muscle contraction; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; ISO:RGD.
DR   CDD; cd15299; 7tmA_mAChR_M3; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 2.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR001183; Musac_Ach_M3_rcpt.
DR   InterPro; IPR000995; Musac_Ach_rcpt.
DR   PANTHER; PTHR24247; 5-HYDROXYTRYPTAMINE RECEPTOR; 1.
DR   PANTHER; PTHR24247:SF183; MUSCARINIC ACETYLCHOLINE RECEPTOR M3; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00243; MUSCARINICR.
DR   PRINTS; PR00540; MUSCRINICM3R.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Direct protein sequencing; Disulfide bond;
KW   Endoplasmic reticulum; G-protein coupled receptor; Glycoprotein; Membrane;
KW   Phosphoprotein; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Synapse; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..589
FT                   /note="Muscarinic acetylcholine receptor M3"
FT                   /id="PRO_0000069034"
FT   TOPO_DOM        1..66
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:22358844"
FT   TRANSMEM        67..90
FT                   /note="Helical; Name=1"
FT   TOPO_DOM        91..103
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:22358844"
FT   TRANSMEM        104..129
FT                   /note="Helical; Name=2"
FT   TOPO_DOM        130..141
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:22358844"
FT   TRANSMEM        142..163
FT                   /note="Helical; Name=3"
FT   TOPO_DOM        164..183
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:22358844"
FT   TRANSMEM        184..205
FT                   /note="Helical; Name=4"
FT   TOPO_DOM        206..228
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:22358844"
FT   TRANSMEM        229..251
FT                   /note="Helical; Name=5"
FT   TOPO_DOM        252..490
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:22358844"
FT   TRANSMEM        491..513
FT                   /note="Helical; Name=6"
FT   TOPO_DOM        514..525
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:22358844"
FT   TRANSMEM        526..545
FT                   /note="Helical; Name=7"
FT   TOPO_DOM        546..589
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:22358844"
FT   REGION          323..356
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           274..280
FT                   /note="Basolateral sorting signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        323..351
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         384
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERZ3"
FT   CARBOHYD        6
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        15
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        48
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        52
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        140..220
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:22358844"
FT   DISULFID        516..519
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:22358844"
FT   MUTAGEN         148
FT                   /note="Y->A: Decreased affinity for acetylcholine."
FT                   /evidence="ECO:0000269|PubMed:1657592"
FT   MUTAGEN         231
FT                   /note="T->A: Decreased affinity for acetylcholine."
FT                   /evidence="ECO:0000269|PubMed:1657592"
FT   MUTAGEN         234
FT                   /note="T->A: Strongly decreased affinity for
FT                   acetylcholine."
FT                   /evidence="ECO:0000269|PubMed:1527051,
FT                   ECO:0000269|PubMed:1657592"
FT   MUTAGEN         506
FT                   /note="Y->F: Decreased affinity for acetylcholine."
FT                   /evidence="ECO:0000269|PubMed:1527051,
FT                   ECO:0000269|PubMed:1657592"
FT   MUTAGEN         529
FT                   /note="Y->F: Decreased affinity for acetylcholine."
FT                   /evidence="ECO:0000269|PubMed:1657592"
FT   MUTAGEN         533
FT                   /note="Y->F: Decreased affinity for acetylcholine."
FT                   /evidence="ECO:0000269|PubMed:1657592"
FT   CONFLICT        184
FT                   /note="A -> R (in Ref. 1; AAA40661/AAA40662 and 4;
FT                   BAA36839)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        516
FT                   /note="C -> R (in Ref. 3; AAA40659)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        556
FT                   /note="T -> M (in Ref. 3; AAA40659)"
FT                   /evidence="ECO:0000305"
FT   HELIX           65..94
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   STRAND          96..98
FT                   /evidence="ECO:0007829|PDB:5ZHP"
FT   HELIX           102..118
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   HELIX           120..129
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   STRAND          130..132
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   HELIX           137..170
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   STRAND          173..175
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   TURN            176..178
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   HELIX           181..210
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   HELIX           224..226
FT                   /evidence="ECO:0007829|PDB:5ZHP"
FT   HELIX           228..238
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   HELIX           240..253
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   HELIX           291..295
FT                   /evidence="ECO:0007829|PDB:5ZHP"
FT   HELIX           304..307
FT                   /evidence="ECO:0007829|PDB:5ZHP"
FT   HELIX           483..502
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   HELIX           504..513
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   STRAND          517..519
FT                   /evidence="ECO:0007829|PDB:4DAJ"
FT   HELIX           522..533
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   HELIX           535..544
FT                   /evidence="ECO:0007829|PDB:4U15"
FT   HELIX           548..556
FT                   /evidence="ECO:0007829|PDB:4U15"
SQ   SEQUENCE   589 AA;  66066 MW;  9A5EF2FA653C830A CRC64;
     MTLHSNSTTS PLFPNISSSW VHSPSEAGLP LGTVTQLGSY NISQETGNFS SNDTSSDPLG
     GHTIWQVVFI AFLTGFLALV TIIGNILVIV AFKVNKQLKT VNNYFLLSLA CADLIIGVIS
     MNLFTTYIIM NRWALGNLAC DLWLSIDYVA SNASVMNLLV ISFDRYFSIT RPLTYRAKRT
     TKRAGVMIGL AWVISFVLWA PAILFWQYFV GKRTVPPGEC FIQFLSEPTI TFGTAIAAFY
     MPVTIMTILY WRIYKETEKR TKELAGLQAS GTEAEAENFV HPTGSSRSCS SYELQQQGVK
     RSSRRKYGRC HFWFTTKSWK PSAEQMDQDH SSSDSWNNND AAASLENSAS SDEEDIGSET
     RAIYSIVLKL PGHSSILNST KLPSSDNLQV SNEDLGTVDV ERNAHKLQAQ KSMGDGDNCQ
     KDFTKLPIQL ESAVDTGKTS DTNSSADKTT ATLPLSFKEA TLAKRFALKT RSQITKRKRM
     SLIKEKKAAQ TLSAILLAFI ITWTPYNIMV LVNTFCDSCI PKTYWNLGYW LCYINSTVNP
     VCYALCNKTF RTTFKTLLLC QCDKRKRRKQ QYQQRQSVIF HKRVPEQAL
//
